These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16490933

  • 21. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [Abstract] [Full Text] [Related]

  • 22. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
    Fujimoto T, Kimura A, Ameno M, Shiiki H, Dohi K.
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
    [Abstract] [Full Text] [Related]

  • 23. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
    Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CG, Moguilevsky N, Limburg PC, Tervaert JW.
    J Immunol Methods; 2001 Aug 01; 254(1-2):47-58. PubMed ID: 11406152
    [Abstract] [Full Text] [Related]

  • 24. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
    Ooi JD, Gan PY, Chen T, Eggenhuizen PJ, Chang J, Alikhan MA, Odobasic D, Holdsworth SR, Kitching AR.
    Kidney Int; 2014 Dec 01; 86(6):1140-9. PubMed ID: 24869670
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Case of immune complex crescentic glomerulonephritis with consistently high titers of MPO-ANCA for 6 years].
    Ayada M, Matsuo T, Takada S, Kusaura T, Suda S, Okado T, Mori Y, Tajima M, Kuwahara M, Kobayashi Y, Tsukamoto Y, Sasaki S.
    Nihon Jinzo Gakkai Shi; 2007 Dec 01; 49(5):511-6. PubMed ID: 17695814
    [Abstract] [Full Text] [Related]

  • 29. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A, Xiao H, Falk RJ, Jennette JC.
    J Am Soc Nephrol; 2006 Dec 01; 17(12):3355-64. PubMed ID: 17108314
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of prognostic factors for myeloperoxidase anti-neutrophil cytoplasmic antibody- (MPO-ANCA) associated glomerulonephritis.
    Okano K, Yumura W, Nitta K, Honda K, Uchida K, Nihei H.
    Clin Nephrol; 2001 Apr 01; 55(4):275-81. PubMed ID: 11334312
    [Abstract] [Full Text] [Related]

  • 31. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
    Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC.
    Am J Pathol; 2007 Jan 01; 170(1):52-64. PubMed ID: 17200182
    [Abstract] [Full Text] [Related]

  • 32. [MPO-positive cells and extracellular MPO in the glomeruli of MPO-ANCA-associated glomerulonephritis].
    Kawashima S, Arimura Y, Nakabayashi K, Yamada A.
    Nihon Jinzo Gakkai Shi; 2009 Jan 01; 51(1):56-67. PubMed ID: 19238910
    [Abstract] [Full Text] [Related]

  • 33. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y, Ito F, Suzuki O, Koura M, Matsuoka S, Kobayashi T, Sugitani Y, Wali N, Koyanagi A, Hino O, Suzuki S, Sugamata R, Yoshizawa H, Yumura W, Maruyama N, Kameoka Y, Noda Y, Hasegawa Y, Arai T, Suzuki K.
    Autoimmunity; 2019 Jan 01; 52(5-6):208-219. PubMed ID: 31476889
    [Abstract] [Full Text] [Related]

  • 34. Renal neutrophils infiltration in antineutrophil cytoplasmic antibodies-negative pauci-immune crescentic glomerulonephritis.
    Xing GQ, Chen M, Liu G, Wang SX, Zhao MH.
    Am J Med Sci; 2010 Dec 01; 340(6):474-80. PubMed ID: 21119331
    [Abstract] [Full Text] [Related]

  • 35. [MPO-ANCA positive rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with D-penicillamine].
    Nanke Y, Akama H, Terai C, Hara M, Kamatani N.
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Oct 01; 22(5):354-9. PubMed ID: 10616290
    [Abstract] [Full Text] [Related]

  • 36. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW.
    Am J Kidney Dis; 2005 Aug 01; 46(2):253-62. PubMed ID: 16112043
    [Abstract] [Full Text] [Related]

  • 37. The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.
    Ooi JD, Chang J, Hickey MJ, Borza DB, Fugger L, Holdsworth SR, Kitching AR.
    Proc Natl Acad Sci U S A; 2012 Sep 25; 109(39):E2615-24. PubMed ID: 22955884
    [Abstract] [Full Text] [Related]

  • 38. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
    van Timmeren MM, van der Veen BS, Stegeman CA, Petersen AH, Hellmark T, Collin M, Heeringa P.
    J Am Soc Nephrol; 2010 Jul 25; 21(7):1103-14. PubMed ID: 20448018
    [Abstract] [Full Text] [Related]

  • 39. [A case of MPO-ANCA-related nephritis caused by an anti-tuberculosis drug].
    Tanaka H, Oshiro Y, Kawanaka N, Kawasaki F, Okimotoi N.
    Nihon Jinzo Gakkai Shi; 2013 Jul 25; 55(2):172-6. PubMed ID: 23631305
    [Abstract] [Full Text] [Related]

  • 40. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
    Arimura Y, Minoshima S, Kamiya Y, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Sasaki T, Suzuki K.
    Clin Nephrol; 1993 Nov 25; 40(5):256-64. PubMed ID: 8281714
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.